Encorafenib plus cetuximab (EC) plus FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
Tabernero, J., Yoshino, T., Kim, T., Yaeger, R., Desai, J., Wasan, H.,…Kopetz, S. (2024). Encorafenib plus cetuximab (EC) plus FOLFIRI … Read More
